Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder — POLE

Observational Clinical Trial

Official title:
A 8-Week, Multicenter, Open-Label, Observational Study of Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder

Status Completed

Clinical Trial Summary

The purpose of this study is to reassure the clinical study data on atypical antipsychotics effect on quality of life in Korean Bipolar patients.

Clinical Trial Description

n/a

Study Design

N/A

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00745966
Study type	Observational
Source	AstraZeneca
Contact
Status	Completed
Phase	N/A
Start date	July 2008

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT01168570` - Progression of Renal Amyloidosis of FMF and Relation to Serum SAA Level	N/A
Completed	`NCT03548753` - Use of FFR-CT in Stable Intermediate Chest Pain Patients With Severe Coronary Calcium Score
Completed	`NCT03138772` - Tracking CF Lung Disease Through the Early Years: Utility of the LCI
Completed	`NCT00233649` - DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines	Phase 4
Recruiting	`NCT03728829` - Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
Recruiting	`NCT03253536` - Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma	N/A
Not yet recruiting	`NCT05693714` - Adenovirus Infection in Children With Autoimmune Hepatitis
Completed	`NCT02922205` - Stapler Post-market Observational Study